Clinical aspects of nitric oxide and surfactant replacement

Neonatology

Volumn 71, Issue 1, 1997, Pages 39-43

  Frostell, Claes G ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; NITROGEN OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL FEATURE; GAS EXCHANGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG INJURY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARGININE; HUMANS; INFANT, NEWBORN; LUNG DISEASES; NITRIC OXIDE; PULMONARY SURFACTANTS;

ANIMALIA;

EID: 0031007820     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244453     Document Type: Article

References (37)

1. Moncada S, Higgs A: The -arginine-nitric oxide pathway, N Engl J Med 1993;329:2002-2012.
2. Arggârd E: Nitric oxide: Mediator, murderer, and medicine, Lancet 1994:343:1199-1206.
3. Frostcll CG, Fratacci M-D, Wain JC, Joncs R, Zapol WM: Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction, Circulation 1991.83:2038-2047.
4. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension, Lancet 1991:338:1173-1174.
5. Bein T, Pfeifer M, Ricggcr FAJ, Taeger K: Continuous intraartcrial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure, N Engl J Med 1994;331:335-336.
6. Walmrath D, Schneider T, Scher-muly R, Olschcwski H, Grimminger F, Sccgcr W: Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome, Am J Respir Crit Care Med 1996;153:991-996.
7. Rimar S, Gillis CN: Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation, Circulation 1993:88:2884-2887.
8. Rossaint R, Falkc KJ, Lopez F, Sla-ma K, Pison U, Zapol WM: Inhaled nitric oxide in adult respiratory distress syndrome, N Engl J Med 1993: 328:399-405.
9. Gcrlach H, Rossaint R, Pappcrt D, Falke KJ: Time-coursc and dosc-rcsponse of nitric oxide inhalation for systemic oxygenation ar, d pulmonary hypertension in patients with adult respiratory distress syndrome, Eur J Clin Invest 1993:23: 499-502.
10. Hess D, Bigatello L, Kacmarck RM, Ritz R, Head CA, Hurford WE: Use of inhaled nitric oxide in patients with acute respiratory' distress syndrome, Respir Care 1996:41:424-446.
11. Frostcll CG, Zapol WM: Inhaled nitric oxide and related nitric oxide donors in the lung: A transatlantic review; in Feclisch M, Stamler J (eds): Methods in Nitric Oxide Research, Chichester, Wiley, 1996. pp 645-659.
12. Gustafsson LE, Leone AM, Pcrsson MG, Wiklund NP, Moncada S: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans, Biochem Biophys ResCommun 1991;181:852-857.
13. Gerlach H, Rossaint R, Pappcrt D, Knorr M, Falkc KJ: Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx, Lancet 1994: 343:518-519.
14. Schcdin U, Frostcll C, Pcrsson MG, Jacobsson J, Andcrsson G, Gustafsson LE: Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans, Acta Anaesthcsiol Scand 1995:39:327- 332.
15. Lundbcrg JON, Rinder J, Wcitzberg E, Lundbcrg JM, Alving K: Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses, Acta Physiol Scand 1994:152: 431-432.
16. Schcdin U, Norman M, Gustafsson LE, Herin P, Frostcll CG: Endogenous nitric oxide in the upper airways of healthy newborn infants, PcdiatrRes 1996:40:148-151.
17. Schcdin U, Frostcll C, Gustafsson LE: Nitric oxide occurs in high concentrations in monkey upper airways, Acta Physiol Scand 1995:155: 473-474.
18. Schcdin U, Frostcll C, Gustafsson L: High endogenous nitric oxide in the upper airways of monkeys, Am J Respir Crit Care Med 1996: 153(suppl):A692.
19. Stamler JS: Redox signaling: Nitro-sylation and related target interactions of nitric oxide, Cell 1994:78: 931-936.
20. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singcl DJ, Loscalzo J: S-Nitrosyla-tion of proteins with nitric oxide: Synthesis and characterization of biologically active compounds, Proc Natl Acad Sci USA 1992:89:444-448.
21. Lindwall R, Nilsson G, Frostcll C, Curstedt T: Effect of nitric oxide on surfactant protein SP-C in vitro (abstract) FASEB J 1995:9:A860.
22. Wagner HM: Absorption von NO und NOj in M1K- und MAK-Kon-zcntrationcn bci der Inhalation, Staub Rcinhalt Luft 1970:30:380-381.
23. Hugod C: Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung, Int Arch Occup Environ Health 1979: 42:159-167.
24. Frampton MW, Morrow PE, Cox C, Gibb FR, Speers DM, Utcll MJ: Effects of nitrogen dioxide exposure on pulmonary function and airway reactivity in normal humans, Am RevRespirDis 1991:143:522-527.
25. Evans MJ, Stephens RJ, Cabral LJ; Freeman G: Cell renewal in the lungs of rats exposed to low levels of NCK Arch Environ Health 1972;24: 180-188.
26. Stenqvist O, Kjelltoft B, Lundin S: Evaluation of a new system for ventilatory administration of nitric oxide, Acta Anacsthcsiol Scand 1993; 37:687-691.
27. Gaston B, Drazcn JM, Loscalzo J, Stander JS: The biology of nitrogen oxides in the airways, Am J Respir Crit Care Med 1994;149:538-551.
28. Radi R, Beckman JS, Bush KM, Freeman BA: Peroxynitrite oxidation of sulfhydryls, J Biol Chem 1991;266:4244-4250.
29. Müller B, Schäfer H, Barth P, von Wiehert P: Lung surfactant components in bronchoalveolar lavage after inhalation of NOj as markers of altered surfactant metabolism, Lung 1994:172:61-72.
30. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Mata-lon S: Mechanisms of peroxvnitrite-induced injury to pulmonary surfactants, Am J Physiol 1993;265:L555- L564.
31. Müller B, Barth P, von Wiehert P: Structural and functional impairment of surfactant protein A after exposure to nitrogen dioxide in rats, Am J Physiol 1992;263:L177-L184.
32. Mercer RR, Costa DL, Crapo JD: Effect of prolonged exposure to low doses of nitric oxide or nitrogen dioxide on the alveolar septa of the adult rat lung, Lab Invest 1995;73: 20-28.
33. Tannenbaum SR: Safety evaluation of inhaled nitric oxide; in Zapol WM, Block KD (eds): Nitric Oxide and the Lung, New York, Marcel Dekkcr, 1997. pp 247-250.
34. Gommers D, Houmcs RJM, Olsson SG, So KL, Lachmann B: Exogenous surfactant and nitric oxide have a synergetic effect in improving respiratory failure (abstract), Am J Respir Crit Care Med 1994; 149:568.
35. Lönnqvist P-A, Winberg P, Lundcll B, Sellden H, Olsson GL: Inhaled nitric oxide in neonates and children with pulmonary hypertension, Acta Paediatr 1994:83:1 132-1136.
36. Müller W, Kachel W, Lasch P, Varnholt V, König SA: Inhaled nitric oxide for avoidance of cxtracor-poreal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn, Intensive Care Med 1996:22: 71-76.
37. Frostell CG: Nitric oxide inhalation: Future drug or invitation to disaster? Paediatr Anaesth 1994:4:147- 150